Will a quadruple multiplexed point-of-care screening strategy for HIV-related co-infections be feasible and impact detection of new co-infections in at-risk populations? Results from cross-sectional studies

BMJ Open

Volumn 4, Issue 12, 2014, Pages

  Pai, Nitika Pant ^a,c   Dhurat, Rachita ^b   Potter, Martin ^c,d   Behlim, Tarannum ^c   Landry, Geneviève ^d   Vadnais, Caroline ^c   Rodrigues, Camilla ^e   Joseph, Lawrence ^a   Shetty, Anjali ^e  

^a MCGILL UNIVERSITY   (Canada)

^b LOKMANYA TILAK MUNICIPAL MEDICAL COLLEGE AND GENERAL HOSPITAL   (India)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^d Centre de Recherche et Aide Aux Narcomanes   (Canada)

^e P D HINDUJA NATIONAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANADA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEASIBILITY STUDY; FEMALE; GOLD STANDARD; HEPATITIS B; HEPATITIS C; HIGH RISK POPULATION; HIV ELISA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MULTIPLEXED POINT OF CARE TESTING; POINT OF CARE TESTING; PREDICTIVE VALUE; SCREENING TEST; SERODIAGNOSIS; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; TREPONEMA PALLIDUM HEMAGGLUTINATION TEST; COINFECTION; COMPLICATION; EVALUATION STUDY; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS; INCIDENCE; MASS SCREENING; MIDDLE AGED; PROCEDURES; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE; YOUNG ADULT;

ADULT; CANADA; COINFECTION; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B; HEPATITIS C; HIV; HIV INFECTIONS; HUMANS; INCIDENCE; INDIA; MALE; MASS SCREENING; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE, INTRAVENOUS; SYPHILIS; YOUNG ADULT;

EID: 84920518633     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-005040     Document Type: Article

References (33)

1. WHO. Global summary of the AIDS epidemic - December 2006. WHO, 2006 (cited 14 September 2009). http://www.who.int/hiv/mediacentre/02-Global-Summary-2006-EpiUpdate-eng.pdf
2. WHO U. Global Aids Response progress reporting 2014. 2014.
3. sheet Wf. 2014. http://www.who.int/mediacentre/factsheets/fs164/en/. (12 August 2014).
4. WHO. Hepatitis B fact sheet. 2014 (12 August 2014). http://www.who.int/mediacentre/factsheets/fs204/en/
5. WHO, UNAIDS, unicef. Global HIV/AIDS response: report update and health sector progress towards Universal Access, progress report. 2011.
6. Klein MB, Willemot P, Murphy T, et al. The impact of initial highly active antiretroviral therapy on future treatment sequences in HIV infection. AIDS 2004;18:1895-904.
7. Abuse CCoS. Injection Drug Users Overview. 2011 (updated 21 June 2013). http://www.ccsa.ca/Eng/Topics/Populations/IDU/Pages/InjectionDrugUsersOverview.aspx
8. Archiblad CP, Jayaraman GC, Major C, et al. Estimating the size of hard-to-reach populations: a novel method using HIV testing data compared to other methods. AIDS 2001;15(Suppl 3):S41-8.
9. Challacombe L. The epidemiology of HIV in people who inject drugs in Canada. 2013.
10. UNAIDS. Ambitious treatment targets: writing the final chapter of the AIDS epidemic. Geneva, Switzerland: UNAIDS, 2014.
11. Ronald A, Kuypers J, Lukehart SA, et al. Excellence in sexually transmitted infection (STI) diagnostics: recognition of past successes and strategies for the future. Sex Transm Infect 2006;82(Suppl 5):v47-52.
12. De Cock KM, Bunnell R, Mermin J. Unfinished business - expanding HIV testing in developing countries. N Engl J Med 2006;354:440-2.
13. De Cock KM, Crowley SP, Lo YR, et al. Preventing HIV transmission with antiretrovirals. Bull World Health Organ 2009;87:488-488A.
14. Granich RM, Gilks CF, Dye C, et al. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 2009;373:48-57.
15. Weinhardt LS, Carey MP, Johnson BT, et al. Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985-1997. Am J Public Health 1999;89:1397-405.
16. Klein MB, Lalonde RG, Suissa S. The impact of hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2003;33:365-72.
17. Steinbrook R. HIV in India - a complex epidemic. N Engl J Med 2007;356:1089-93.
18. Public Health Agency of Canada. Summary: Estimates of HIV Prevalence and Incidence in Canada, 2011. 2011 (cited 1 December 2013). http://www.phac-aspc.gc.ca/aids-sida/publication/survreport/estimat2011-eng.php
19. LeBlanc M. What the syph is going on? Responding to syphilis outbreaks in Canada. 2013 (21 January 2014). http://www.catie.ca/en/printpdf/pif/spring-2013/what-syph-going-responding-syphilis-outbreaks-canada
20. Kitahata MM, Gange SJ, Abraham AG, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 2009;360:1815-26.
21. Pai NP, Vadnais C, Denkinger C, et al. Point-of-care testing for infectious diseases: diversity, complexity, and barriers in low- and middle-income countries. PLoS Med 2012;9:e1001306.
22. Jafari Y, Peeling RW, Shivkumar S, et al. Are Treponema pallidum specific rapid and point-of-care tests for syphilis accurate enough for screening in resource limited settings? Evidence from a meta-analysis. PLoS ONE 2013;8:e54695.
23. Pai NP, Balram B, Shivkumar S, et al. Head-to-head comparison of accuracy of a rapid point-of-care HIV test with oral versus whole-blood specimens: a systematic review and meta-analysis. Lancet Infect Dis 2012;12:373-80.
24. Shivkumar S, Peeling RW, Jafari Y, et al. Accuracy of rapid and point-of-care screening tests for hepatitis C: a systematic review and meta-analysis. Ann Intern Med 2012;157:558-66.
25. Shivkumar S, Peeling R, Jafari Y, et al. Rapid point-of-care first-line screening tests for hepatitis B infection: a meta-analysis of diagnostic accuracy (1980-2010). Am J Gastroenterol 2012;107:1306-13.
26. Smith BD, Drobeniuc J, Jewett A, et al. Evaluation of three rapid screening assays for detection of antibodies to hepatitis C virus. J Infect Dis 2011;204:825-31.
27. Lochhead MJ, Todorof K, Delaney M, et al. Rapid multiplexed immunoassay for simultaneous serodiagnosis of HIV-1 and coinfections. J Clin Microbiol 2011;49:3584-90.
28. Cha YJ, Park Q, Kang ES, et al. Performance evaluation of the OraQuick hepatitis C virus rapid antibody test. Ann Lab Med 2013;33:184-9.
29. CDC. Testing for HCV Infection: An Update of Guidance for Clinicians and Laboratorians. 2013.
30. French AL, Operskalski E, Peters M, et al. Isolated hepatitis B core antibody is associated with HIV and ongoing but not resolved hepatitis C virus infection in a cohort of US women. J Infect Dis 2007;195:1437-42.
31. Witt MD, Lewis RJ, Rieg G, et al. Predictors of the isolated hepatitis B core antibody pattern in HIV-infected and -uninfected men in the multicenter AIDS cohort study. Clin Infect Dis 2013;56:606-12.
32. Waldeisen JR, Wang T, Mitra D, et al. A real-time PCR antibiogram for drug-resistant sepsis. PLoS ONE 2011;6:e28528.
33. Pai NP, Pai M. Point-of-care diagnostics for HIV and tuberculosis: landscape, pipeline, and unmet needs. Discov Med 2012;13:35-45.